辅助化疗治疗的病理N2期非小细胞肺癌术后放疗：随机对照证据的必要性。 - Suppr | 超能文献

相似文献

1

Postoperative Radiotherapy for Pathologic N2 Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: Need for Randomized Evidence.辅助化疗治疗的病理N2期非小细胞肺癌术后放疗：随机对照证据的必要性。

J Clin Oncol. 2015 Sep 10;33(26):2930-1. doi: 10.1200/JCO.2015.62.1458. Epub 2015 Jul 27.

2

[Prognostic benefit of postoperative radiotherapy with adjuvant chemotherapy for stage IIIA/N2, pathologic non-small-cell lung cancer].[ⅢA/N2期病理非小细胞肺癌术后放疗联合辅助化疗的预后获益]

Strahlenther Onkol. 2015 Jun;191(6):539-40. doi: 10.1007/s00066-015-0835-1.

3

Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.术后放疗治疗辅助化疗后病理 N2 期非小细胞肺癌：国家癌症数据库综述。

J Clin Oncol. 2015 Mar 10;33(8):870-6. doi: 10.1200/JCO.2014.58.5380. Epub 2015 Feb 9.

4

Caveat for Immortal Time Bias in Adjuvant Therapy-Related Population-Based Analyses.辅助治疗相关基于人群分析中永生时间偏倚的注意事项。

J Clin Oncol. 2015 Sep 10;33(26):2931. doi: 10.1200/JCO.2015.62.3306. Epub 2015 Jul 27.

5

Reply to C. Le Péchoux et al and B.S. Gill et al.对C.勒佩舒等人及B.S.吉尔等人的回复

J Clin Oncol. 2015 Sep 10;33(26):2932-3. doi: 10.1200/JCO.2015.62.5731. Epub 2015 Jul 27.

6

A multi-institutional randomized phase III trial comparing postoperative radiotherapy to observation after adjuvant chemotherapy in patients with pathological N2 Stage III non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1916 (J-PORT study).一项多机构随机 III 期临床试验，比较了辅助化疗后病理 N2 期 III 期非小细胞肺癌患者接受术后放疗与观察的效果：日本临床肿瘤学组研究 JCOG1916（J-PORT 研究）。

Jpn J Clin Oncol. 2021 May 28;51(6):999-1003. doi: 10.1093/jjco/hyab037.

7

Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.术后放疗对接受辅助化疗的完全切除且处于Ⅰ期、Ⅱ期或ⅢA期非小细胞肺癌患者生存的影响：辅助长春瑞滨国际协作组（ANITA）随机试验

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):695-701. doi: 10.1016/j.ijrobp.2008.01.044. Epub 2008 Apr 24.

8

Perioperative therapy of non-small cell lung cancer: a review of adjuvant and neoadjuvant approaches.非小细胞肺癌的围手术期治疗：辅助和新辅助治疗方法综述

Semin Oncol. 1995 Dec;22(6):571-81.

9

Neoadjuvant and adjuvant therapy of non-small cell lung cancer.非小细胞肺癌的新辅助治疗和辅助治疗

Surg Oncol. 2002 Dec;11(4):243-53. doi: 10.1016/s0960-7404(02)00048-8.

10

Adjuvant chemotherapy in non-small cell lung cancer (NSCLC).非小细胞肺癌的辅助化疗

Ann Oncol. 2007 Jul;18 Suppl 9:ix143-6. doi: 10.1093/annonc/mdm309.

引用本文的文献

1

Postoperative intensity-modulated radiation therapy reduces local recurrence and improves overall survival in III-N2 non-small-cell lung cancer: A single-center, retrospective study.术后调强放疗降低 III-N2 期非小细胞肺癌局部复发率并提高总生存率：一项单中心回顾性研究。

Cancer Med. 2020 Apr;9(8):2820-2832. doi: 10.1002/cam4.2937. Epub 2020 Feb 26.

2

Postoperative chemoradiotherapy is superior to postoperative chemotherapy alone in squamous cell lung cancer patients with limited N2 lymph node metastasis.术后放化疗优于单纯术后化疗，适用于存在局限性 N2 淋巴结转移的鳞状细胞肺癌患者。

BMC Cancer. 2019 Oct 30;19(1):1023. doi: 10.1186/s12885-019-6141-z.

3